4/13
04:33 pm
pfe
Rating for PFE
Low
Report
Rating for PFE
4/10
11:36 am
pfe
Rating for PFE
Low
Report
Rating for PFE
4/10
11:36 am
pfe
Rating for PFE
Low
Report
Rating for PFE
3/24
07:33 am
pfe
Rating for PFE
Low
Report
Rating for PFE
3/24
07:33 am
pfe
Rating for PFE
Low
Report
Rating for PFE
3/17
11:58 am
pfe
Rating for PFE
Low
Report
Rating for PFE
3/17
11:58 am
pfe
Rating for PFE
Low
Report
Rating for PFE
3/9
01:06 pm
pfe
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
Low
Report
Pfizer (PFE) had its "outperform" rating reaffirmed by BMO Capital Markets.
3/2
12:49 pm
pfe
Rating for PFE
Low
Report
Rating for PFE
3/2
08:03 am
pfe
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
Low
Report
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
3/2
08:03 am
pfe
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
Low
Report
Pfizer (PFE) was upgraded by Argus from "hold" to "buy". They now have a $35.00 price target on the stock.
3/2
07:29 am
pfe
Pfizer upgraded to Buy from Hold at Argus
Low
Report
Pfizer upgraded to Buy from Hold at Argus
3/2
07:29 am
pfe
Pfizer upgraded to Buy from Hold at Argus
Low
Report
Pfizer upgraded to Buy from Hold at Argus
2/26
06:28 am
pfe
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
Low
Report
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
2/26
06:28 am
pfe
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
Low
Report
Pfizer (PFE) was upgraded by Royal Bank Of Canada to "strong sell".
2/25
09:59 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/25
09:59 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/24
04:06 pm
pfe
Pfizer initiated with an Underperform at RBC Capital
Low
Report
Pfizer initiated with an Underperform at RBC Capital
2/24
04:06 pm
pfe
Pfizer initiated with an Underperform at RBC Capital
Low
Report
Pfizer initiated with an Underperform at RBC Capital
2/21
06:31 am
pfe
Pfizer (NYSE:PFE) was upgraded by analysts at Barclays PLC to a "strong sell" rating.
Low
Report
Pfizer (NYSE:PFE) was upgraded by analysts at Barclays PLC to a "strong sell" rating.
2/20
10:01 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/20
10:01 am
pfe
Rating for PFE
Low
Report
Rating for PFE
2/19
08:01 pm
pfe
Pfizer (NYSE:PFE) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.
Low
Report
Pfizer (NYSE:PFE) is now covered by analysts at Barclays PLC. They set an "underweight" rating on the stock.
2/19
04:17 pm
pfe
Pfizer initiated with an Underweight at Barclays
Low
Report
Pfizer initiated with an Underweight at Barclays
2/19
04:17 pm
pfe
Pfizer initiated with an Underweight at Barclays
Low
Report
Pfizer initiated with an Underweight at Barclays